Actively Recruiting
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
Led by Northwell Health · Updated on 2025-08-19
40
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.
CONDITIONS
Official Title
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 85 years
- Confirmed diagnosis of spinal facet arthropathy on MRI or CT
- Confirmed lumbosacral facetogenic pain based on diagnostic nerve blocks
- Back pain lasting at least 6 months with pain level worse than 6 out of 10
- Failed medical management of pain
- Failed at least one treatment of intra-articular steroid/anesthetic injections or neuro-ablative procedure
- Maximum of 2 spinal levels affected in lumbar and sacral spine (e.g., L4-5 and L5-S1)
- Modified Rankin Scale score between 0 and 2
You will not qualify if you...
- Pregnancy
- Prior spinal embolization at the target level
- History of surgery or stenting of the aorta at the embolization level
- Severe allergic reaction to iodinated contrast (such as anaphylaxis)
- Creatinine level greater than 1.5 mg/dl or creatinine clearance less than 60 mL/min unless on hemodialysis
- Modified Rankin Scale score greater than 2
- Vascular supply to the spinal cord from vessels supplying the facet joints targeted for embolization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
North Shore University Hospital
Manhasset, New York, United States, 11030
Actively Recruiting
Research Team
B
Betsy Moclair
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here